You are here

Regenerative Medicine and COVID-19

A new Perspective article from researchers led by Joshua Hunsberger (Wake Forest University School of Medicine ‐ Wake Forest Institute for Regenerative Medicine, Winston‐Salem, NC, USA) and published in STEM CELLS Translational Medicine critically evaluates some of the promising regenerative medicine‐based therapies for treating COVID‐19 and presents some of the collective technologies and resources that the scientific community currently has available to confront this pandemic.

Additionally, the Regenerative Medicine Manufacturing Society (RMMS) and STEM CELLS Translational Medicine have collaborated to create a platform on the Stem Cells Portal ( to share regenerative medicine resources in order to address the COVID‐19 pandemic in three areas: models, cell therapies, and technologies. This information will be made publicly available and developed further by RMMS in future webinars and perspective articles.